Position in INCY
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$12,823,002
+$160,590 QoQ
Shares Held
136,241
+6.3% QoQ
Ownership
0.068%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Treasurer of the State of North Carolina holds $227,922,242 across 22 Biotechnology names. INCY ranks #6 (5.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
108,663 | $48,522,376 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
60,382 | $46,653,548 | |
| 3 | RPRX |
Royalty Pharma plc
|
544,033 | $26,097,263 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
54,269 | $17,955,984 | |
| 5 | INSM |
INSMED Inc
|
89,647 | $14,659,077 | |
| 6 | INCY |
Incyte Corp
This page
|
136,241 | $12,823,002 | |
| 7 | EXEL |
Exelixis, Inc.
|
276,296 | $11,850,335 | |
| 8 | MRNA |
Moderna, Inc.
|
153,407 | $7,793,075 |
All Filings in INCY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $12,823,002 | 136,241 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $12,662,412 | 128,201 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $6,032,704 | 71,132 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $5,032,521 | 73,899 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,406,102 | 72,768 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $5,334,207 | 77,229 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $4,819,284 | 72,909 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $5,535,090 | 91,308 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $5,128,496 | 90,021 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $5,586,489 | 88,971 | Shares | Sole | 2024-05-09 | |
| 2023-09-30 | $5,154,066 | 89,217 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $5,532,904 | 88,882 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $6,281,130 | 86,912 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $6,575,155 | 81,862 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $5,380,646 | 80,742 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $6,073,953 | 79,952 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $5,611,737 | 70,659 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $5,227,254 | 71,216 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $4,809,854 | 69,931 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $5,694,086 | 67,682 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $5,721,570 | 70,402 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $6,076,596 | 69,862 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $6,247,878 | 69,622 | Shares | Sole | 2020-11-04 | |
| 2020-06-30 | $7,248,996 | 69,722 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $5,642,151 | 77,047 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||